[ad_1] WASHINGTON (Reuters) – The United States said on Friday it would add 33 Chinese firms and institutions to an economic blacklist for helping Beijing spy on its minority Uighur population or because of ties
UK plans cut in Huawei’s 5G network involvement -newspaper report
[ad_1] (Reuters) – Prime Minister Boris Johnson is planning to reduce Chinese telecoms equipment maker Huawei Technologies Co Ltd’s involvement in Britain’s 5G network in the wake of the coronavirus crisis, the Daily Telegraph newspaper
Deutsche Bank asks more senior managers to waive one month of fixed pay
[ad_1] FILE PHOTO: The logo of Deutsche Bank is pictured on a company’s office in London, Britain July 8, 2019. REUTERS/Simon Dawson/File Photo (Reuters) – Deutsche Bank AG (DBKGn.DE) said on Friday it has asked
UK eyes cuts to Huawei’s 5G network involvement in wake of COVID-19 – report
[ad_1] Britain’s Prime Minister Boris Johnson opens the Hidden Harms Summit via Zoom from the White Room of 10 Downing Street during COVID-19 in London, Britain May 21, 2020. Andrew Parsons/10 Downing Street/Handout via REUTERS
Johnson plans to cut Huawei’s involvement in UK’s 5G network – The Telegraph
[ad_1] Britain’s Prime Minister Boris Johnson opens the Hidden Harms Summit via Zoom from the White Room of 10 Downing Street during COVID-19 in London, Britain May 21, 2020. Andrew Parsons/10 Downing Street/Handout via REUTERS
U.S. adding 33 Chinese companies, institutions to economic blacklist
[ad_1] WASHINGTON (Reuters) – The U.S. Commerce Department said on Friday it was adding 33 Chinese companies and other institutions to an economic blacklist for human rights violations and to address U.S. national security concerns
Evofem’s gel first non-hormonal contraceptive to get approval in over 30 years
[ad_1] (Reuters) – Evofem Biosciences Inc’s (EVFM.O) birth control gel received the U.S. Food and Drug Administration’s approval on Friday, making it the first non-hormonal contraceptive for women in over three decades, sending its shares
Wall Street mixed as China-U.S. tensions weigh
[ad_1] (Reuters) – Wall Street was mixed on Friday in a mostly tame finish to a week of strong gains, as investors gauged China-U.S. tensions and amid ongoing uncertainty about the pace of economic recovery
Evofem non-hormonal birth control gel gets FDA approval, to be priced at up to $275
[ad_1] (Reuters) – The U.S. Food and Drug Administration on Friday approved Evofem Biosciences Inc’s birth control gel, ushering in the first non-hormonal contraceptive for women in over three decades, sending its shares up 3.6%.
Wall Street Week Ahead: Investors look beyond drug makers as hunt for Covid-19 treatment heats up
[ad_1] NEW YORK (Reuters) – Investors are diversifying bets in the healthcare sector, as the rush to develop treatments for Covid-19 has driven up prices for some pharmaceutical stocks. FILE PHOTO: A man wears a